Cited 0 times in
Personalized medicine in breast cancer: a systematic review
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김승일 | - |
dc.date.accessioned | 2014-12-19T17:01:46Z | - |
dc.date.available | 2014-12-19T17:01:46Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1738-6756 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/90644 | - |
dc.description.abstract | The recent advent of "-omics" technologies have heralded a new era of personalized medicine. Personalized medicine is referred to as the ability to segment heterogeneous subsets of patients whose response to a therapeutic intervention within each subset is homogeneous. This new paradigm in healthcare is beginning to affect both research and clinical practice. The key to success in personalized medicine is to uncover molecular biomarkers that drive individual variability in clinical outcomes or drug responses. In this review, we begin with an overview of personalized medicine in breast cancer and illustrate the most encountered statistical approaches in the recent literature tailored for uncovering gene signatures. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | JOURNAL OF BREAST CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Personalized medicine in breast cancer: a systematic review | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학) | - |
dc.contributor.googleauthor | Sang-Hoon Cho | - |
dc.contributor.googleauthor | Jongsu Jeon | - |
dc.contributor.googleauthor | Seung Il Kim | - |
dc.identifier.doi | 23091538 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00658 | - |
dc.relation.journalcode | J01279 | - |
dc.identifier.eissn | 2092-9900 | - |
dc.identifier.pmid | 23091538 | - |
dc.subject.keyword | Biomarker discovery | - |
dc.subject.keyword | Breast neoplasms | - |
dc.subject.keyword | Individualized medicine | - |
dc.subject.keyword | Predictive biomarker | - |
dc.subject.keyword | Prognostic biomarker | - |
dc.contributor.alternativeName | Kim, Seung Il | - |
dc.contributor.affiliatedAuthor | Kim, Seung Il | - |
dc.citation.volume | 15 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 265 | - |
dc.citation.endPage | 272 | - |
dc.identifier.bibliographicCitation | JOURNAL OF BREAST CANCER, Vol.15(3) : 265-272, 2012 | - |
dc.identifier.rimsid | 33437 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.